These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 3088172)

  • 1. [Significance of fecal Bacteroides in hepatic encephalopathy with hyperammonemia].
    Tarao K
    Kansenshogaku Zasshi; 1986 Jan; 60(1):15-24. PubMed ID: 3088172
    [No Abstract]   [Full Text] [Related]  

  • 2. [Clinical significance of anaerobic gram-negative bacteria in hepatic encephalopathy and the therapeutic effects of vancomycin hydrochloride on hepatic encephalopathy].
    Tarao K; Ikeda T; Hayashi K; Sakurai A
    Nihon Shokakibyo Gakkai Zasshi; 1985 Aug; 82(8):1875-83. PubMed ID: 4068308
    [No Abstract]   [Full Text] [Related]  

  • 3. [Effects of lactitol on fecal bacterial flora in patients with liver cirrhosis and hepatic encephalopathy].
    Tarao K; Tamai S; Ito Y; Okawa S; Hayashi M
    Nihon Shokakibyo Gakkai Zasshi; 1995 Jul; 92(7):1037-50. PubMed ID: 7643458
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Successful use of vancomycin hydrochloride in the treatment of lactulose resistant chronic hepatic encephalopathy.
    Tarao K; Ikeda T; Hayashi K; Sakurai A; Okada T; Ito T; Karube H; Nomoto T; Mizuno T; Shindo K
    Gut; 1990 Jun; 31(6):702-6. PubMed ID: 2199349
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Therapeutic efficacy of vancomycin hydrochloride, a nonabsorbable antibiotic, on intractable (lactulose resistant) chronic hepatic encephalopathy in cirrhotic patients].
    Tarao K; Ikeda T; Hayashi K; Sakurai A; Tsuchiya T; Ito T
    Nihon Shokakibyo Gakkai Zasshi; 1986 May; 83(5):1006-14. PubMed ID: 3747231
    [No Abstract]   [Full Text] [Related]  

  • 6. Rifaximin ameliorates hepatic encephalopathy and endotoxemia without affecting the gut microbiome diversity.
    Kaji K; Takaya H; Saikawa S; Furukawa M; Sato S; Kawaratani H; Kitade M; Moriya K; Namisaki T; Akahane T; Mitoro A; Yoshiji H
    World J Gastroenterol; 2017 Dec; 23(47):8355-8366. PubMed ID: 29307995
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of lactulose on the faecal flora of patients with hepatic encephalopathy.
    Vince A; Zeegen R; Drinkwater JE; O'Grady F; Dawson AM
    J Med Microbiol; 1974 May; 7(2):163-8. PubMed ID: 4600290
    [No Abstract]   [Full Text] [Related]  

  • 8. Successful use of vancomycin hydrochloride in the treatment of lactulose-resistant chronic hepatic encephalopathy.
    Tarao K; Ikeda T; Hayashi K; Sakurai A
    J Gastroenterol Hepatol; 1989; 4 Suppl 1():284-6. PubMed ID: 2519078
    [No Abstract]   [Full Text] [Related]  

  • 9. Ammonia levels and the severity of hepatic encephalopathy.
    Qureshi MO; Khokhar N; Shafqat F
    J Coll Physicians Surg Pak; 2014 Mar; 24(3):160-3. PubMed ID: 24613109
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fecal transplant to mitigate hyperammonemia and hepatic encephalopathy in animal models.
    Kang DJ; Hylemon PB; Bajaj JS
    Ann Hepatol; 2015; 14(5):762-3. PubMed ID: 26256908
    [No Abstract]   [Full Text] [Related]  

  • 11. [Prevention and treatment of hepatic encephalopathy].
    Sivolap YP
    Zh Nevrol Psikhiatr Im S S Korsakova; 2017; 117(10):144-147. PubMed ID: 29171503
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Changes in arterial blood ammonia levels in cirrhosis. Study during and after mannitol lavage in post-hemorrhagic hepatic encephalopathy].
    Doffoel M; Kopferschmitt J; Coumaros D; Girard M; Bockel R
    Nouv Presse Med; 1978 Sep; 7(29):2575. PubMed ID: 309107
    [No Abstract]   [Full Text] [Related]  

  • 13. Helicobacter pylori, hyperammonemia, and hepatic encephalopathy: is there a correlation?
    Rinaldi V; Zullo A; Diana F; Capocaccia L
    Am J Gastroenterol; 1997 Apr; 92(4):723-4. PubMed ID: 9128348
    [No Abstract]   [Full Text] [Related]  

  • 14. [The treatment of hepatic encephalopathy with Hepa-Mertz].
    Podymova SD; Bueverov AO; Nadinskaia MIu
    Ter Arkh; 1995; 67(6):45-7. PubMed ID: 7667779
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treating hepatic encephalopathy in cirrhotic patients admitted to ICU with sodium phenylbutyrate: a preliminary study.
    Weiss N; Tripon S; Lodey M; Guiller E; Junot H; Monneret D; Mayaux J; Brisson H; Mallet M; Rudler M; Imbert-Bismut F; Thabut D;
    Fundam Clin Pharmacol; 2018 Apr; 32(2):209-215. PubMed ID: 29239015
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The effects of Helicobacter pylori infection on hyperammonaemia and hepatic encephalopathy in cirrhotic patients].
    Wang LJ; Cai JT; Chen T; Lü B; Si JM
    Zhonghua Nei Ke Za Zhi; 2006 Aug; 45(8):654-7. PubMed ID: 17074151
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of hyperammonemia in liver failure.
    Jover-Cobos M; Khetan V; Jalan R
    Curr Opin Clin Nutr Metab Care; 2014 Jan; 17(1):105-10. PubMed ID: 24281376
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ammonia-lowering strategies for the treatment of hepatic encephalopathy.
    Rose CF
    Clin Pharmacol Ther; 2012 Sep; 92(3):321-31. PubMed ID: 22871998
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Action of antibiotics on arterial hyperammonemia induced in liver cirrhosis patients by diuretics causing hypokalemia].
    Imler M; Bockel R; Peter B; Stahl J
    Pathol Biol (Paris); 1971; 19(11):567-73. PubMed ID: 4933620
    [No Abstract]   [Full Text] [Related]  

  • 20. Ammonia encephalopathy.
    Peltz S; Schwartzman S; Cohen B
    N J Med; 1989 Jul; 86(7):554-6. PubMed ID: 2755616
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.